Income Statement (TTM)
Cannara Biotech Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 11-30 |
2021 02-28 |
2021 05-31 |
2021 08-31 |
2021 11-30 |
2022 02-28 |
2022 05-31 |
2022 08-31 |
2022 11-30 |
2023 02-28 |
2023 05-31 |
2023 08-31 |
2023 11-30 |
2024 02-29 |
2024 05-31 |
2024 08-31 |
2024 11-30 |
2025 02-28 |
2025 05-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 5 | 11 | 17 | 22 | 27 | 30 | 36 | 40 | 45 | 51 | 57 | 66 | 73 | 77 | 82 | 87 | 94 | 102 |
| Change (%) | 46.94 | 128.55 | 49.69 | 30.53 | 23.25 | 10.61 | 18.34 | 10.26 | 13.73 | 13.64 | 12.11 | 16.04 | 10.25 | 4.48 | 6.81 | 6.76 | 7.79 | 8.28 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 3 | 3 | 6 | 7 | 9 | 13 | 16 | 19 | 20 | 24 | 26 | 30 | 36 | 43 | 48 | 52 | 56 | 55 | 57 |
| Change (%) | -1.13 | 86.21 | 15.64 | 30.92 | 48.21 | 19.74 | 18.49 | 8.29 | 21.79 | 8.31 | 13.58 | 19.21 | 18.91 | 12.32 | 8.68 | 7.01 | -1.64 | 3.41 | |
| % of Revenue | 93.28 | 62.77 | 51.14 | 39.50 | 39.62 | 47.65 | 51.58 | 51.64 | 50.72 | 54.32 | 51.77 | 52.44 | 53.88 | 58.11 | 62.47 | 63.56 | 63.71 | 58.14 | 55.52 |
| Gross Operating Profit | 0 | 2 | 6 | 10 | 13 | 14 | 15 | 17 | 19 | 21 | 25 | 27 | 31 | 31 | 29 | 30 | 32 | 39 | 45 |
| Change (%) | 714.75 | 199.92 | 85.33 | 30.28 | 6.86 | 2.30 | 18.19 | 12.36 | 5.43 | 19.99 | 10.53 | 12.55 | 0.15 | -6.40 | 3.69 | 6.33 | 24.34 | 15.06 | |
| % of Revenue | 6.72 | 37.23 | 48.86 | 60.50 | 60.38 | 52.35 | 48.42 | 48.36 | 49.28 | 45.68 | 48.23 | 47.56 | 46.12 | 41.89 | 37.53 | 36.44 | 36.29 | 41.86 | 44.48 |
| SG&A | 8 | 7 | 7 | 7 | 8 | 9 | 10 | 10 | 11 | 11 | 13 | 14 | 15 | 17 | 18 | 20 | 21 | 21 | 22 |
| Change (%) | -13.80 | -0.95 | 5.42 | 3.66 | 16.56 | 11.40 | 1.98 | 10.47 | 2.68 | 11.46 | 6.65 | 7.53 | 17.09 | 6.26 | 8.62 | 6.72 | 0.34 | 4.11 | |
| % of Revenue | 239.68 | 140.60 | 60.94 | 42.92 | 34.08 | 32.23 | 32.46 | 27.97 | 28.03 | 25.31 | 24.82 | 23.61 | 21.88 | 23.24 | 23.63 | 24.03 | 24.03 | 22.37 | 21.50 |
| R&D | 3 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 2.69 | -27.73 | -18.46 | -15.41 | -23.37 | -5.95 | 8.10 | -3.19 | -4.94 | -9.29 | -1.73 | -0.60 | 7.24 | 7.95 | -5.50 | -3.43 | -13.72 | -18.51 | |
| % of Revenue | 93.07 | 65.05 | 20.57 | 11.20 | 7.26 | 4.51 | 3.84 | 3.51 | 3.08 | 2.57 | 2.05 | 1.80 | 1.54 | 1.50 | 1.55 | 1.37 | 1.24 | 0.99 | 0.75 |
| OpEx | 16 | 14 | 16 | 17 | 19 | 24 | 28 | 31 | 34 | 38 | 41 | 46 | 52 | 62 | 68 | 74 | 79 | 78 | 81 |
| Change (%) | -9.78 | 13.00 | 5.45 | 11.85 | 27.27 | 14.99 | 11.70 | 8.40 | 13.61 | 8.20 | 10.16 | 15.14 | 17.69 | 10.33 | 8.84 | 6.47 | -1.18 | 3.26 | |
| % of Revenue | 466.15 | 286.20 | 141.51 | 99.69 | 85.42 | 88.21 | 91.70 | 86.55 | 85.10 | 85.01 | 80.94 | 79.54 | 78.92 | 84.24 | 88.96 | 90.65 | 90.41 | 82.88 | 79.03 |
| Operating Income | -12 | -9 | -5 | 0 | 3 | 3 | 3 | 5 | 6 | 7 | 10 | 12 | 14 | 12 | 8 | 8 | 8 | 16 | 21 |
| Change (%) | -25.28 | -49.05 | -101.11 | 6,057.57 | -0.30 | -22.20 | 91.81 | 22.20 | 14.38 | 44.50 | 20.38 | 19.53 | -17.58 | -26.81 | -9.55 | 9.56 | 92.34 | 32.62 | |
| % of Revenue | -366.15 | -186.20 | -41.51 | 0.31 | 14.58 | 11.79 | 8.30 | 13.45 | 14.90 | 14.99 | 19.06 | 20.46 | 21.08 | 15.76 | 11.04 | 9.35 | 9.59 | 17.12 | 20.97 |
| Interest Expense | -1 | -1 | -1 | -2 | -2 | -2 | -2 | -2 | -3 | -3 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -4 |
| Change (%) | 2.51 | 6.38 | 17.23 | 13.94 | 8.01 | -24.23 | 39.85 | 24.56 | 26.02 | 35.50 | 0.05 | 1.81 | 3.35 | 1.92 | -0.65 | -3.10 | -7.34 | -9.28 | |
| % of Revenue | -39.49 | -27.55 | -12.82 | -10.04 | -8.77 | -7.68 | -5.26 | -6.22 | -7.03 | -7.79 | -9.28 | -8.28 | -7.27 | -6.81 | -6.65 | -6.18 | -5.61 | -4.82 | -4.04 |
| Net Income | -13 | -11 | -7 | -2 | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 7 | 9 | 6 | 5 | 6 | 7 | 13 | 16 |
| Change (%) | -20.11 | -38.45 | -76.56 | -194.00 | -19.71 | -23.37 | 160.85 | 23.14 | 18.59 | 44.57 | 42.70 | 30.30 | -31.26 | -14.55 | 21.12 | 3.08 | 101.87 | 15.81 | |
| % of Revenue | -391.59 | -212.90 | -57.34 | -8.98 | 6.47 | 4.21 | 2.92 | 6.43 | 7.18 | 7.49 | 9.53 | 12.13 | 13.62 | 8.49 | 6.95 | 7.88 | 7.60 | 14.24 | 15.23 |
Source: Capital IQ
